Leveraging AI for data collection and management has the power to accelerate the clinical trials process, and enhance patient-engagement. Ahead of the Disruptive Technology for Clinical Trials Summit, we spoke to clinical trials technology experts to uncover the biggest barriers to AI adoption and best practice strategies to overcome them.

Complete the form to download the complimentary article and learn from:

• Amir Emadzadeh, Director, Data Science, Gilead Sciences
• Stephen Lutsch, Former Director, Head of Revolutionize Clinical Trials, Leo Pharma
• Jen Yip, Associate Director, Digital Trials & Patient Engagement, Novartis
• Emilie Louvet, Director, Clinical Information Science AstraZeneca